Summary: Mounjaro and Wegovy are both weekly GLP-1 receptor agonist injections for weight loss, but they vary in their actions, with Mounjaro being a dual receptor agonist, and Wegovy also approved for reducing cardiovascular risk
Stopping GLP1-RAs without a management plan may lead to worsening control of diabetes and excessive weight gain, both of which are associated with pregnancy complications
1 2 3 "Binding energy, vapor pressure, and melting point of semiconductor nanoparticles"
In the context of weight loss, different peptides target different mechanisms: Appetite regulation: Some peptides mimic gut hormones like GLP-1 and GIP that signal satiety to the brain Fat metabolism: Others stimulate lipolysis (fat breakdown) or inhibit lipogenesis (fat storage) Growth hormone optimization: GH-releasing peptides improve body composition by increasing fat oxidation and preserving lean muscle mass Insulin sensitivity: Several peptides improve how the body processes glucose, reducing fat storage Unlike over-the-counter weight loss supplements, these peptides are prescription medications or clinically administered therapies that have been studied in controlled trials
We increase your dose gradually to reduce side effects
